NCT00558168已完成不适用
Electronic Study for Anastrozole Pharmacovigilance Evaluation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,850
研究概览
简要总结
Collecting information regarding adverse events from patients on treatment with anastrazole with early stage breast cancer
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Post-menopausal Early Invasive Breast Cancer Patients who are under anastrazole treatment, who have normal renal and hepatic functions.
排除标准
- •Metastatic breast cancer patients, previous hormonal therapy, other malignancies.
研究者
相似试验
已完成
4 期
A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast CancerBreast CancerNCT00544986AstraZeneca
已完成
4 期
Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast CancerBreast CancerNCT00082277AstraZeneca237
已完成
2 期
Arimidex in McCune Albright SyndromeMcCune-Albright SyndromeNCT00055302AstraZeneca40
已完成
不适用
A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood PressureHypertensionNCT05107960Takeda5
Unknown
4 期
STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)Breast CancerNCT00126360St George Hospital, Australia100